1. Home
  2. LUNR vs SUPN Comparison

LUNR vs SUPN Comparison

Compare LUNR & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intuitive Machines Inc.

LUNR

Intuitive Machines Inc.

HOLD

Current Price

$23.88

Market Cap

3.2B

Sector

Industrials

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$50.56

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LUNR
SUPN
Founded
2013
2005
Country
United States
United States
Employees
525
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
LUNR
SUPN
Price
$23.88
$50.56
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$20.83
$61.60
AVG Volume (30 Days)
14.0M
499.5K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$392,755,000.00
Revenue This Year
$342.04
$22.72
Revenue Next Year
$16.63
$18.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.75
$29.16
52 Week High
$25.00
$59.68

Technical Indicators

Market Signals
Indicator
LUNR
SUPN
Relative Strength Index (RSI) 60.92 48.14
Support Level $15.87 $47.43
Resistance Level N/A $52.25
Average True Range (ATR) 2.37 1.56
MACD 0.46 0.15
Stochastic Oscillator 89.40 56.58

Price Performance

Historical Comparison
LUNR
SUPN

About LUNR Intuitive Machines Inc.

Intuitive Machines Inc is a space infrastructure and services company focused on enabling sustained human activity beyond Earth. It designs, builds, integrates, and operates space systems, offering infrastructure-as-a-service across low Earth orbit, geostationary orbit, cislunar space, and deep space. Its capabilities include spacecraft development and space-based network connectivity, serving commercial, civil, and national security customers. The company conducts sales both directly and through an extensive customer and partner network spanning North America, South America, Europe, Asia, and Australia, including rideshare delivery providers, lunar surface mobility providers, payload providers, communication satellite providers, and ground segment providers.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: